» Authors » Alijan Tabarraei

Alijan Tabarraei

Explore the profile of Alijan Tabarraei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 668
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Azadfar S, Yamchi A, Majd A, Tabarraei A
Iran J Allergy Asthma Immunol . 2025 Mar; 24(1):79-88. PMID: 40052892
Human cytomegalovirus glycoprotein B (gB) emerges as a viable candidate for eliciting neutralizing antibodies. This research specifically focused on exploring the immune reaction prompted by the nonglycosylated variant of the...
2.
Hamidi Sofiani V, Ebrahimian Shiadeh A, Tabarraei A, Nikoo H, Sadeghi F, Kamrani G, et al.
J Int Med Res . 2024 Dec; 52(12):3000605241302302. PMID: 39673361
Objective: This study aimed to explore the potential relationship between viral infections and gastrointestinal (GI) malignancies, focusing on the presence of KRAS G12D mutations. Specifically, we investigated the association of...
3.
Divbandi M, Yamchi A, Nikoo H, Moradi A, Tabarraei A
AMB Express . 2024 Oct; 14(1):113. PMID: 39363125
The functionality of Moloney murine leukemia virus reverse transcriptase (MMLV RT) will increase with the improvement of its solubility and thermal stability. Introduce directed mutation at specific positions of the...
4.
Rafiee M, Tabarraei A, Yazdi M, Ghaemi E
BMC Res Notes . 2024 Jul; 17(1):200. PMID: 39039580
Objective: This study aimed to introduce a lytic bacteriophage against Staphylococcus saprophyticus from wastewater in Gorgan, northern Iran. Results: The vB_SsapS-46 phage was isolated from urban wastewater and formed round...
5.
Javadi-Farsani F, Karimi A, Nikoo H, Moradi M, Tabarraei A
Avicenna J Phytomed . 2024 Jul; 14(4):496-504. PMID: 38952775
Objective: Influenza complications are mild to serious, and can cause death in some cases. A great deal of attention has been paid in recent years to the development and use...
6.
Ebrahimian Shiadeh A, Hamidi Sofiani V, Saber Amoli S, Taheri M, Tabarraei A, Nikoo H, et al.
Int J Mol Cell Med . 2024 May; 12(3):288-299. PMID: 38751659
Viral infections contribute to 15-20% of newly diagnosed cancers worldwide. There is evidence of a possible etiological role of Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HR-HPVs) in colorectal carcinoma...
7.
Letafati A, Bahavar A, Tabarraei A, Norouzi M, Amiri A, Mozhgani S
Infect Agent Cancer . 2024 May; 19(1):23. PMID: 38734673
Introduction: Human T-cell Lymphotropic virus type 1 (HTLV-1) belongs to retroviridae which is connected to two major diseases, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and Adult T-cell leukemia/lymphoma (ATLL). This...
8.
Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar M, Rahimi A, Teimoori-Toolabi L, et al.
AMB Express . 2024 May; 14(1):53. PMID: 38722404
Using herpes simplex virus type 1 (HSV-1) as a therapeutic tool has recently emerged as a promising strategy for enhancing the treatment of various cancers, particularly those associated with the...
9.
Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar M, Teimoori-Toolabi L, Azadmanesh K
PLoS One . 2023 Oct; 18(10):e0286231. PMID: 37862369
Oncolytic viruses (OVs) have emerged as a novel cancer treatment modality, which selectively target and kill cancer cells while sparing normal ones. Among them, engineered Herpes simplex virus type 1...
10.
Ashrafi F, Mohseni M, Beheshtian M, Fattahi Z, Ghodratpour F, Keshavarzi F, et al.
Arch Iran Med . 2023 Aug; 26(2):69-75. PMID: 37543926
Background: Global real-time monitoring of SARS-CoV-2 variants is crucial to controlling the COVID-19 outbreak. The purpose of this study was to set up a Sanger-based platform for massive SARS-CoV-2 variant...